실리콘 기반 타원편광계식 바이오센서를 이용한 심근경색 생체표지자의 실시간 초고감도 진단 농도 측정
Real-Time Highly Sensitive Measurement of Myocardial Infarction Biomarkers Using Silicon-Based Ellipsometric Biosensors
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
기울어진 산화막 코팅 실리콘 기판의 바이오칩과 프리즘으로 제작한 바이오센서와 검광자 회전 타원편광계를 이용하여 심근경색 생체표지자인 미오글로빈과 cTnI의 진단 농도를 수백 초 내에 실시간 초고감도로 측정하는데 성공하였다. 러닝 버퍼로는 순수한 phosphate buffered saline (PBS) 또는 PBS에 10% 인간 혈청을 섞은 러닝 버퍼를 사용하였다. PBS 조건에서는 미오글로빈과 cTnI가 각각 1 ng/mL와 5 pg/mL로 측정되었으며, PBS에 인간 혈청을 10% 섞은 조건에서는 미오글로빈과 cTnI는 각각 1 ng/mL과 1 pg/mL로 측정되었다. 이러한 심근경색 생체표지자의 진단 농도는 현재 제시된 세계보건기구의 심근경색 진단 기준 농도보다 미오글로빈은 1/15배 낮고, cTnI는 1/80배 낮다.
Abstract
We report highly sensitive detection of myocardial infarction biomarkers, such as myoglobin and cTnI, within several hundred seconds using a rotating-analyzer ellipsometer and a biosensor with biochips fabricated on a SiO 2 -coated tilted silicon substrate. We choose the running buffer to be pure phosphate-buffered saline (PBS) or 10% mixed human serum. When we choose the running buffer to be pure PBS, we obtain diagnostic densities of pure myocardial infarction biomarkers of up to 1 ng/ml and 5 pg/ml respectively. Meanwhile, when we use PBS with 10% human serum, the measured densities of myoglobin and cTnI were up to 1 ng/mL and 1 pg/mL respectively. The measured diagnostic densities are less than 1/15 and 1/80 (in cases of myoglobin and cTnI respectively) of those referenced by the World Health Organization.
참고문헌 (13)
- M. S. Diware, "Solution immersed silicon(SIS)based biosensors : a new approach in biosensing", Analyst, 140, pp.706~709 (2015)
- J. Homola, "Surface plasmon resonance sensors: review", Sens. Actuators, B, 54, pp.3~15 (1999)
- Y. Tang, "Surface plasmon resonance : An introduction to a surface spectroscopy technique", J. Chem. Educ, 87, pp.742~746 (2010)
- 이근재, "실리콘 기판을 사용한 바이오센서와 회전 타원분광계를 이용한 펩타이드-항체 접합의 동특성 측정과 분석", 한국광학회지, 28(1), pp.9~15 (2017), 한국광학회
- M. S. Diware, "Label-free detection of hepatitis B virus using solution immersed silicon sensors", Biointerphases, 12, pp.01A402~ (2017)
- J. E. Adams III, "Biochemical markers of myocardial injury. Is MB creatine kinase the choice for the 1990s?", Circulation, 88, pp.750~763 (1993)
- H. Tunstall-Pedoe, "Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents", Circulation, 90, pp.588~612 (1994)
- E. Antman, "Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology", American College of Cardiology Committee for the redefinition of myocardial infarction : The Joint European Society of Cardiology, J. Am. Coll. Cardiol, pp.2000, 36[DOI]
- F. S. Apple, "Simultaneous rapid measurement of whole blood myoglobin, creatine kinase MB, and cardiac troponin I by the triage cardiac panel for detection of myocardial infarction", Clin. Chem, 45, pp.199~205 (1999)
- D. A. Morrow, "National academy of clinical biochemistry laboratory medicine practice guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes", Circulation, 115, pp.356~375 (2007)
- J. Rosenblat, "Biomarker of myocardial infarction: past, present and future", Univ. West. Ont. Med. J, 81, pp.23~24 (2012)
- J. Humlicek, "Handbook of Ellipsometry" (2005), William Andrew
- H. Fujiwara, "Spectroscopic Ellipsometry: Principles and Applications" (2007), John Wiley & Sons